- Home
- FUND vs OCGN Comparison
FUND vs OCGN Comparison
Compare FUND & OCGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FUND
- OCGN
- Stock Information
- Founded
- FUND 1988
- OCGN 2013
- Country
- FUND Canada
- OCGN United States
- Employees
- FUND N/A
- OCGN N/A
- Industry
- FUND Investment Managers
- OCGN Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- FUND Finance
- OCGN Health Care
- Exchange
- FUND Nasdaq
- OCGN Nasdaq
- Market Cap
- FUND 228.2M
- OCGN 189.6M
- IPO Year
- FUND N/A
- OCGN N/A
- Fundamental
- Price
- FUND $7.14
- OCGN $0.69
- Analyst Decision
- FUND
- OCGN Strong Buy
- Analyst Count
- FUND 0
- OCGN 3
- Target Price
- FUND N/A
- OCGN $6.33
- AVG Volume (30 Days)
- FUND 32.5K
- OCGN 3.1M
- Earning Date
- FUND 01-01-0001
- OCGN 05-09-2025
- Dividend Yield
- FUND 6.64%
- OCGN N/A
- EPS Growth
- FUND N/A
- OCGN N/A
- EPS
- FUND 0.93
- OCGN N/A
- Revenue
- FUND N/A
- OCGN $4,054,999.00
- Revenue This Year
- FUND N/A
- OCGN N/A
- Revenue Next Year
- FUND N/A
- OCGN N/A
- P/E Ratio
- FUND $8.33
- OCGN N/A
- Revenue Growth
- FUND N/A
- OCGN N/A
- 52 Week Low
- FUND $6.75
- OCGN $0.52
- 52 Week High
- FUND $8.47
- OCGN $2.06
- Technical
- Relative Strength Index (RSI)
- FUND 51.76
- OCGN 48.90
- Support Level
- FUND $7.09
- OCGN $0.65
- Resistance Level
- FUND $7.21
- OCGN $0.75
- Average True Range (ATR)
- FUND 0.10
- OCGN 0.05
- MACD
- FUND 0.03
- OCGN -0.01
- Stochastic Oscillator
- FUND 80.95
- OCGN 30.31
About FUND Sprott Focus Trust Inc.
Sprott Focus Trust Inc is a diversified closed-end investment company. Its primary investment objective is long-term capital growth. To achieve its objective, The Fund may invest its assets in equity securities and in direct obligations of the U.S. Government or its agencies and in the non-convertible preferred stocks & debt securities of domestic and foreign companies. It invests in various sectors, of which Materials, Financials, Energy, Information technology sector account for the majority weightage.
About OCGN Ocugen Inc.
Ocugen Inc company focused on discovering, developing, and commercializing novel gene and cell therapies and vaccines that improve health and offer hope for patients across the globe. The company's pipeline includes Modifier Gene Therapy Platform, Novel Biologic Therapy for Retinal Diseases, Regenerative Medicine Cell Therapy Platform. The company is developing a modifier gene therapy platform designed to fulfill unmet medical needs related to retinal diseases, including inherited retinal diseases ("IRDs"), such as RP, LCA, Stargardt disease, and multifactorial diseases such as dAMD and Geographic Atrophy ("GA").